Organisations can apply for a share of up to £4 million, inclusive of VAT, to enable selected blood-based and digital biomarkers to be evaluated as part of the Bio-Hermes 2 study led by the Global Alzheimer’s Platform Foundation (GAP).
Eligibility summary
To lead a project, you can:
- be an organisation of any size
- work alone or with other organisations as subcontractors
Contracts will be awarded to a single legal entity only.